Patients at Drogheda Hospital Face Re-evaluated Cancer Risk Results

A number of patients at Our Lady of Lourdes Hospital in Drogheda are being informed that their tests for pre-cancerous cells have been incorrectly graded. A review of histopathology slides conducted by a pathologist revealed discrepancies, leading to some patients experiencing significant changes in their findings. One individual, initially classified with mild abnormalities, has seen their grading elevated to “high.”

The hospital is currently organizing “open disclosure” meetings this week for affected patients. These meetings are part of a protocol established after safety incidents, including those resulting in harm and near misses. The meetings aim to provide transparency and support to those impacted by this oversight.

Questions surrounding the incident prompted inquiries from the Irish Independent to the Health Service Executive (HSE) national office and the HSE Dublin and North East region. Initial responses were delayed, with a follow-up inquiry revealing that the matter was under review.

In a statement released by June Molloy, the Communications and Public Affairs Manager for HSE Dublin and North East, it was confirmed that an independent review of histopathology slides had been commissioned. This review will focus on various specialties relating to one consultant, covering a timeframe from February to November 2024. Molloy emphasized that any patients affected by the findings will be contacted directly by the hospital.

Patients have begun receiving letters notifying them of changes in the grading of their pre-cancerous cells. In some cases, the grading has been escalated, while others have experienced a reduction. The situation underlines the importance of accurate reporting in medical diagnostics, as misclassification can significantly impact patient care and treatment plans.

In a foreword to the HSE’s open disclosure policy, Dr. Colm Henry, the Chief Clinical Officer, highlighted the commitment of health and social care staff to provide the best possible care. He stated, “When an incident occurs, our staff and services continue on this path to support those impacted.” Dr. Henry emphasized that open disclosure represents an ethical and patient-centered approach to addressing such incidents, fostering trust and ensuring that patients’ needs remain a priority.

The HSE has also indicated that necessary information has been provided to them according to the National Patient Safety Briefing Protocol. As the review continues, the health authority aims to ensure that all findings are communicated transparently to affected individuals, thereby reinforcing the commitment to patient safety and quality care.

In light of this incident, it is evident that maintaining rigorous standards in medical testing and reporting is crucial for the health of patients. As the hospital navigates this challenging situation, the focus remains on providing accurate information and support to those affected.